Works matching IS 03065251 AND DT 2002 AND VI 53 AND IP 2
1
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 196, doi. 10.1046/j.-5251.2001.01520.x
- Stone, Barbara M;
- Turner, Claire;
- Mills, Sue L;
- Paty, Isabelle;
- Patat, Alain;
- Darwish, Mona;
- Danjou, Philippe
- Article
2
- 2002
- Mucklow, John;
- Waller, Derek
- Book Review
5
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 218, doi. 10.1046/j.0306-5251.2001.01525.x
- Article
6
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 155, doi. 10.1046/j.1365-2125.2002.01522.x
- Frye, Reginald F;
- Branch, Robert A
- Article
7
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 133, doi. 10.1046/j.0306-5251.2001.01182.x
- Swart, Eleonora L;
- van der Hoven, Ben;
- Johan Groeneveld, A. B;
- Touw, Daniel J;
- Danhof, Meindert
- Article
8
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 183, doi. 10.1046/j.0306-5251.2001.01190.x
- Visser, Loes E;
- Graatsma, Hayo H;
- Stricker, Bruno H. Ch
- Article
9
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 173, doi. 10.1046/j.0306-5251.2001.01220.x
- Mellemkjær, Lene;
- Blot, William J;
- Sørensen, Henrik Toft;
- Thomassen, Lars;
- McLaughlin, Joseph K;
- Nielsen, Gunnar Lauge;
- Olsen, Jørgen H
- Article
10
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 189, doi. 10.1046/j.1365-2125.2002.1528adoc.x
- Wilkinson, Ian B;
- MacCallum, Helen;
- Cockcroft, John R;
- Webb, David J
- Article
11
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 211, doi. 10.1046/j.1365-2125.2002.01530.x
- van Heeswijk, Rolf P.G.;
- Stuart, James W.T. Cohen;
- Burger, David M.;
- Beijnen, Jos H.;
- Borleffs, Jan C.C.;
- Hoetelmans, Richard M.W.
- Article
12
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 212, doi. 10.1046/j.0306-5251.2001.01539.x
- Calvo, Rosario;
- Lukas, John C.;
- Rodriguez, Monica;
- Carlos, M. Angeles;
- Suarez, Elena
- Article
13
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 214, doi. 10.1046/j.0306-5251.2001.01538.x
- Article
14
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 163, doi. 10.1046/j.0306-5251.2001.01531.x
- Al-Eidan, F. A;
- McElnay, J. C;
- Scott, M. G;
- McConnell, J. B
- Article
15
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 141, doi. 10.1046/j.0306-5251.2001.01532.x
- Abrams, Larry S;
- Skee, Donna M;
- Natarajan, Jaya;
- Wong, Frankie A;
- Anderson, Gary D
- Article
16
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 147, doi. 10.1046/j.0306-5251.2001.01534.x
- Gaussem, P;
- Dubar, M;
- le Bonniec, B;
- Richard-Lordereau, I;
- Jochemsen, R;
- Aiach, M
- Article
17
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 207, doi. 10.1046/j.0306-5251.2001.01535.x
- Jonville-Béra, Annie Pierre;
- Giraudeau, Bruno;
- Blanc, Pascal;
- Beau-Salinas, Frèdèrique;
- Autret-Leca, Elisabeth
- Article
18
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 123, doi. 10.1046/j.0306-5251.2001.01540.x
- Article
19
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 203, doi. 10.1046/j.0306-5251.2001.01545.x
- Saima, S;
- Furuie, K;
- Yoshimoto, H;
- Fukuda, J;
- Hayashi, T;
- Echizen, H
- Article
20
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 193, doi. 10.1046/j.0306-5251.2001.01546.x
- de Haas, S. L;
- Wilkinson, I. B;
- Boyd, J. L;
- Webb, D. J
- Article
21
- British Journal of Clinical Pharmacology, 2002, v. 53, n. 2, p. 111, doi. 10.1046/j.0306-5251.2001.01548.x
- Bertilsson, Leif;
- Dahl, Marja-Liisa;
- Dalén, Per;
- Al-Shurbaji, Ayman
- Article